These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 36171591)

  • 1. TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC.
    Sun H; Zheng J; Xiao J; Yue J; Shi Z; Xuan Z; Chen C; Zhao Y; Tang W; Ye S; Li J; Deng Q; Zhang L; Zhu F; Shao C
    Cell Death Dis; 2022 May; 13(5):450. PubMed ID: 35546143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours.
    Deng M; Yang R; Sun Q; Zhang J; Miao J
    Basic Clin Pharmacol Toxicol; 2024 May; 134(5):629-642. PubMed ID: 38501576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival.
    Shahab SW; Roggeveen CM; Sun J; Kunhiraman H; McSwain LF; Juraschka K; Kumar SA; Saulnier O; Taylor MD; Schniederjan M; Schnepp RW; MacDonald TJ; Kenney AM
    Mol Oncol; 2023 Sep; 17(9):1784-1802. PubMed ID: 37341142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032.
    Eedara BB; Manivannan B; Alabsi W; Sun B; Curiel-Lewandrowski C; Zhang T; Bode AM; Mansour HM
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study.
    Shi J; Zhang L; Geng C
    Front Oncol; 2023; 13():1210314. PubMed ID: 37664018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOPK inhibits TNF-α-induced granulosa cell apoptosis via regulation of SIRT1/p53.
    Joo NR; Park SA; Park JH; Oh SM
    Biochem Biophys Res Commun; 2023 Jul; 664():128-135. PubMed ID: 37148702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOPK promotes the growth of esophageal cancer in vitro and in vivo by enhancing YB1/eEF1A1 signal pathway.
    Wu W; Xu J; Gao D; Xie Z; Chen W; Li W; Yuan Q; Duan L; Zhang Y; Yang X; Chen Y; Dong Z; Liu K; Jiang Y
    Cell Death Dis; 2023 Jun; 14(6):364. PubMed ID: 37328464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDZ-binding kinase aggravates pancreatic neuroendocrine neoplasm progression by activating the AKT/mTOR pathway.
    Feng T; Jiang R; Yin L; Xu C; Ma J; Yin W; Jin J; Lu T; Liu X; Lyu Y; Yang Y; Ying L; Hu Q; Su D; Ling S
    Mol Carcinog; 2023 May; 62(5):716-726. PubMed ID: 36807309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1.
    Li J; Sun H; Fu M; Zheng Z; Xu C; Yang K; Liu Y; Xuan Z; Bai Y; Zheng J; Zhao Y; Shi Z; Shao C
    iScience; 2023 Jul; 26(7):107185. PubMed ID: 37404377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods.
    Martins S; Coletti R; Lopes MB
    BioData Min; 2023 Sep; 16(1):26. PubMed ID: 37752578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demystifying the Role of Prognostic Biomarkers in Breast Cancer through Integrated Transcriptome and Pathway Enrichment Analyses.
    Mishra D; Mishra A; Nand Rai S; Vamanu E; Singh MP
    Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
    Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
    Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBK/TOPK Expression Predicts Prognosis in Oral Cancer.
    Chang CF; Chen SL; Sung WW; Hsieh MJ; Hsu HT; Chen LH; Chen MK; Ko JL; Chen CJ; Chou MC
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBK/TOPK: A Therapeutic Target Worthy of Attention.
    Han Z; Li L; Huang Y; Zhao H; Luo Y
    Cells; 2021 Feb; 10(2):. PubMed ID: 33670114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.
    Huang H; Lee MH; Liu K; Dong Z; Ryoo Z; Kim MO
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis.
    Qiao L; Ba J; Xie J; Zhu R; Wan Y; Zhang M; Jin Z; Guo Z; Yu J; Chen S; Yao Y
    World J Surg Oncol; 2022 Sep; 20(1):316. PubMed ID: 36171591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.
    Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H
    Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.